Veliparib |
Veliparib : Inhibitor of PARP1 and PARP2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PARP1 |
|
|
| PARP2 |
|
|
Inhibitor
10-100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: Ki - SIRT2 >5,000 nM
Potency Assay Off-Target:
In ADP ribosylation assays for PARP family members, veliparib was >100-fold selective for PARP1 and ...
Selectivity Assessment Description:
In ADP ribosylation assays for PARP family members, veliparib was >100-fold selective for PARP1 and ...
Potency Cellular
In Vitro
PARP1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00990
PARP2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00990
In Vivo Validations
mouse, rat
Dose: 10 mg/kg (mice), 5 mg/kg (rat)
Route of delivery:
Intravenous, Oral
Plasma half life:
1.6 h (mouse IV), 1.2 h (rat IV), 1.3 h (mouse oral), 1.6 h (rat oral)
Systemic clearance:
4.1 L/h/kg (mouse IV), 2.0 L/h/kg (rat IV)
Organ of interest (O):
xenograft tumor, brain, plasma
Target engagement assay:
Indirect: in B16F10 tumors, velaparib inhibited PAR as detected in western blot.
DOI Reference: 10.1158/1078-0432.CCR-06-3039
Chemical Information
| Molecular Formula | C13H16N4O |
| SMILEs | C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1 |
| InChI | InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1 |
| Molecular weight | 244.13 Da |
| AlogP | 1.2604 |
| HBond acceptors | 5 |
| HBond donors | 4 |
| Atoms | 34 |
References
Cross References
GDSCVendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.